HFA celebrates 10 productive years
The Heart Failure Association (HFA) of the ESC will soon be celebrating the tenth anniversary of its foundation. Over the last decade we have undergone an extraordinary growth and developed into a vibrant organisation that has done much to raise the profile of heart failure (HF) in Europe.
Topics:
Heart Failure (HF) (Source: ESC News and Press)
Source: ESC News and Press - May 2, 2014 Category: Cardiology Source Type: news
Eplerenone reduces primary endpoint in acute myocardial infarction patients
A drug known to reduce mortality rate in patients with heart failure has now been found significantly effective when administered early in patients following an acute (ST elevated) myocardial infarction. This effect,say the investigators, was consistent across all study sub-groups, but was "particularly obvious in patients undergoing reperfusion within six hours of symptom onset". Read more
Topics:
Heart Failure (HF) (Source: ESC News and Press)
Source: ESC News and Press - April 28, 2014 Category: Cardiology Source Type: news
HFA Online Learning Programme
“When I became president-elect of the Heart Failure Association (HFA) in2010 I felt it was important for the HFA to develop an online learning programme that would improve the implementation of the latest heart failure (HF) guidelines regarding diagnosis, treatment and management of patients. Therefore, we created the HFA Online Education Committee." says Prof Stefan Anker.
Topics:
Heart Failure (HF) (Source: ESC News and Press)
Source: ESC News and Press - April 24, 2014 Category: Cardiology Source Type: news
Defining Mars and Venus in HF
The Mars-Venus metaphor, popularized by author John Gray, believes Carolyn Lam, applies equally well to the sexual dimorphism that exists in heart failure
Topics:
Heart Failure (HF) (Source: ESC News and Press)
Source: ESC News and Press - April 23, 2014 Category: Cardiology Source Type: news
Safety demonstrated for stem cell delivery technology in HF
A study exploring use of a system allowing standardization of the delivery of autologous mesenchymal stromal cells in heart failure has met its primary safety and efficacy end points.
Topics:
Heart Failure (HF) (Source: ESC News and Press)
Source: ESC News and Press - April 23, 2014 Category: Cardiology Source Type: news
Invitation to attend Heart Failure 2015 in Seville, Spain
We have the honour of inviting you to attend the Heart Failure 2015 meeting that will be held in Seville, Spain, from 23 to 26 May 2015.
Topics:
Heart Failure (HF) (Source: ESC News and Press)
Source: ESC News and Press - April 23, 2014 Category: Cardiology Source Type: news
Study group on Peripartum Cardiomyopathy
The Study Group on Peripartum Cardiomyopathy was formed by the ESC in 2010 with the objective of bringing together specialists from a variety of disciplines to facilitate better understanding and management of women with Peripartum Cardiomyopathy (PPCM).
Topics:
Heart Failure (HF) (Source: ESC News and Press)
Source: ESC News and Press - April 23, 2014 Category: Cardiology Source Type: news
Optimal outcomes require increased vigilance for HF co morbidities
Heart failure (HF), says Mitja Lainscak, should never be viewed in isolation, but considered together with other patient co morbidities.
Topics:
Heart Failure (HF) (Source: ESC News and Press)
Source: ESC News and Press - April 23, 2014 Category: Cardiology Source Type: news
IN-TIME analysis reveals equal telemonitoring benefits for ICD and CRT-D devices
Heart failure patients receive similar benefits from implantable devices fitted with telemonitoring technology alerting medical experts to problems regardless of whether they are fitted with cardioverter defibrillators (ICD) or cardiac resynchronization therapy defibrillators (CRT-D), reported the latest analysis of the IN-TIME trial in yesterday’s Late Breaking Trial session.
Topics:
Heart Failure (HF) (Source: ESC News and Press)
Source: ESC News and Press - April 23, 2014 Category: Cardiology Source Type: news
Why is it important to have awards at medical meetings recognising good research?
When investigators present their work in competitive environments they’re likely to invest far more effort into their presentation skills, and receive greater support from co authors and supervisors, all of which helps with career development. Furthermore, comments from the jury can provide valuable teaching experiences.
Topics:
Heart Failure (HF) (Source: ESC News and Press)
Source: ESC News and Press - April 23, 2014 Category: Cardiology Source Type: news
Voyaging into the parallel universe of micro RNAs
Using the analogy of space travel Thomas Thum believes micro RNAs (miRNAs) represent a part of the dark matter of the genome. “While the Human Genome Project showed humans have around 20,000 different genes, it turned out that only approximately 1.5 % code for proteins and the rest have no obvious function.
Topics:
Heart Failure (HF) (Source: ESC News and Press)
Source: ESC News and Press - April 23, 2014 Category: Cardiology Source Type: news
